Roivant Sciences Ltd. (ROIV)

Revenue by Segment

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019
Pharmaceuticals	8.26M	29.05M	32.71M	31.53M	55.29M
Pharmaceuticals Growth	-71.57%	-11.19%	3.75%	-42.97%	132.34%
Total	8.26M	29.05M	32.71M	31.53M	55.29M
Total Growth	-71.57%	-11.19%	3.75%	-42.97%	132.34%

Data Source: S&P Global Market Intelligence Last updated: May 20, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 26, 2026

Data Sources Report a data error